Targeting AML with Multi-Antigen Specific T Cells Engineered to Express a CAR Specific for SSX2 Peptide 41-49

被引：0
|
作者：
Pezzella, Gloria [1 ]
Achour, Achouak [1 ]
Yvon, Eric S. [2 ]
Bollard, Catherine M. [1 ,2 ]
Toner, Keri [1 ,2 ]
机构：
[1] Childrens Natl Hosp, Washington, DC USA
[2] George Washington Univ, Washington, DC USA
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
142
引用
收藏
页码：77 / 78
页数：2
相关论文
共 50 条
  • [31] Overcoming the Challenge of Transduction of Human T-cells with Chimeric Antigen Receptor (CAR) Specific for ERBB2 Antigen
    Munisvaradass, Rusheni
    Lee, Shirley Ding Suet
    Koh, Avin Ee Hwan
    Kumar, Suresh
    Nian, Lim Moon
    Vellasamy, Shalini
    Abdullah, Syahril
    Alarfaj, Abdullah A.
    Ling, Mok Pooi
    SAINS MALAYSIANA, 2017, 46 (10): : 1831 - 1838
  • [32] Engineered T cells modified to express a CS-1-specific chimeric antigen receptor ( CAR) confer anti-myeloma activity in vitro and in pre-clinical in vivo models
    Gogishvili, T.
    Danhof, S.
    Brede, C.
    Beilhack, A.
    Kunzmann, V.
    Einsele, H.
    Hudecek, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S16 - S16
  • [33] Engineered T cells modified to express a CS-1-specific CAR confer anti-myeloma activity in vitro and in preclinical in vivo models
    Gogishvili, T.
    Danhof, S.
    Sommermeyer, D.
    Brede, C.
    Beilhack, A.
    Kunzmann, V.
    Einsele, H.
    Hudecek, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 202 - 202
  • [34] A unique strategy to arm iPSC-derived CAR-T cells to perform antibody-directed cellular cytotoxicity to facilitate multi-antigen targeting.
    Hosking, Martin
    Shirinbak, Soheila
    Grant, Joy
    Yeh, Wen-I
    Pan, Yijia
    Pribadi, Mochtar
    Mehta, Amit
    Yzaguirre, Amanda
    Chu, Philip
    Sikaroodi, Shohreh
    Gentile, Angela
    Walcheck, Bruce
    Wu, Jianming
    Nguyen, Anhco
    Valamehr, Bahram
    CANCER RESEARCH, 2021, 81 (13)
  • [35] Phase 1/2 Study of Nexi-001 Donor-Derived Multi-Antigen Specific CD8+T Cells for the Treatment of Relapsed Acute Myeloid Leukemia (AML) after Allogeneic Hematopoietic Transplantation
    Al Malki, Monzr M.
    Vasu, Sumithira
    Modi, Dipenkumar
    Perales, Miguel-Angel
    Ghoda, Lucy Y.
    Bui, Donna
    Edavana, Vineetha
    Lu, Emily
    Kim, Sojung
    Suarez, Lauren
    Oelke, Mathias
    Bednarik, Daniel
    Knight, Robert D.
    Varela, Juan C.
    BLOOD, 2021, 138
  • [36] T Cells engineered to express the IL-13Rα2 specific CAR and a PD-L1 specific switch receptor show increased anti-tumor activity in the Glioblastoma tumor microenvironment
    De Castro, Abel
    Keys, Megan E.
    Arroyo, Jonathan
    Prosser, Megan E.
    CANCER RESEARCH, 2018, 78 (13)
  • [37] Multi-Antigen Targeting By Novel Combination of CAR-T Cells and hnCD16 Transgene, Yields in Complete Tumor Clearance Via Antibody Dependent Cellular Cytotoxicity
    Shirinbak, Soheila
    Grant, Joy
    Yeh, Wen-, I
    Gentile, Angela
    Shrestha, Bishwas
    Yang, Bi-Huei
    Pribadi, Mochtar
    Sikaroodi, Shohreh
    Mehta, Amit
    Yzaguirre, Amanda D.
    Pan, Yijia
    Chang, Chia-Wei
    Lee, Tom
    Smith, Layton
    Wu, Jianming
    Walcheck, Bruce
    Hosking, Martin
    Valamehr, Bahram
    BLOOD, 2022, 140 : 10253 - 10254
  • [38] Preclinical Targeting of Human Acute Myeloid Leukemia Using CD4-specific Chimeric Antigen Receptor (CAR) T Cells and NK Cells
    Salman, Huda
    Pinz, Kevin G.
    Wada, Masayuki
    Shuai, Xiao
    Yan, Lulu E.
    Petrov, Jessica C.
    Ma, Yupo
    JOURNAL OF CANCER, 2019, 10 (18): : 4408 - 4419
  • [39] eNovel GD2-specific chimeric antigen receptor-modified T cells targeting osteosarcoma
    Chulanetra, Monrat
    Sayour, Elias
    Eldjerou, Lamis
    Lagmay, Joanne
    Milner, Rowan
    Slayton, William
    Chang, Lung-Ji
    CANCER RESEARCH, 2015, 75
  • [40] Development of piggyBac Transposon-Mediated GD2 Specific CAR-T Cells Targeting Neuroblastoma
    Tomida, Akimasa
    Yagyu, Shigeki
    Yamashima, Kumiko
    Yoshida, Hideki
    Miyachi, Mitsuru
    Tsuchiya, Kunihiko
    Iehara, Tomoko
    Nakazawa, Yozo
    Hosoi, Hajime
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S14 - S15
12345